Haleon (NYSE:HLN) Upgraded by Wall Street Zen to Buy Rating

Haleon (NYSE:HLN - Get Free Report) was upgraded by research analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a research note issued to investors on Friday.

A number of other research firms have also commented on HLN. Morgan Stanley raised shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price objective on the stock in a research note on Friday, May 9th. Hsbc Global Res lowered Haleon from a "strong-buy" rating to a "hold" rating in a report on Wednesday, March 5th. HSBC reiterated a "hold" rating on shares of Haleon in a report on Wednesday, March 5th. BNP Paribas Exane raised shares of Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price objective on the stock in a research report on Tuesday, May 27th. Finally, Barclays reissued an "overweight" rating on shares of Haleon in a research report on Tuesday, May 6th. Five equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $12.33.

Haleon Stock Down 1.7%

Shares of HLN stock traded down $0.19 on Friday, hitting $10.88. 15,090,851 shares of the stock were exchanged, compared to its average volume of 8,779,907. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The business has a 50-day moving average of $10.51 and a 200 day moving average of $10.04. The firm has a market capitalization of $48.99 billion, a P/E ratio of 32.00, a price-to-earnings-growth ratio of 2.82 and a beta of 0.31. Haleon has a fifty-two week low of $8.25 and a fifty-two week high of $11.42.

Institutional Investors Weigh In On Haleon

Hedge funds have recently bought and sold shares of the business. Bartlett & CO. Wealth Management LLC boosted its stake in Haleon by 135.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company's stock worth $27,000 after acquiring an additional 1,491 shares in the last quarter. Sierra Ocean LLC bought a new stake in Haleon in the fourth quarter worth $26,000. Banque Transatlantique SA bought a new stake in Haleon in the first quarter worth $27,000. Opal Wealth Advisors LLC bought a new stake in Haleon in the first quarter worth $29,000. Finally, Ransom Advisory Ltd bought a new stake in Haleon in the first quarter worth $31,000. Institutional investors own 6.67% of the company's stock.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.